Original Post by Dealer (3 hours ago):
Zydus +2.5% on earnings, Sun +1.8% on pipeline. Both up in Nifty surge. Portfolio heavy on Zydus - switch or double down?
Reply by PipelinePro (1 hour ago):
Sun's biosimilars edge. Balanced 50-50.
Reply by GenericGuy (30 mins ago):
Zydus for US focus. Both to 1,800.